A 2-part Phase 1/2 Open-label Trial on ODM-212
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Mesothelioma · Pancreatic Cancer · NSCLC (Advanced Non-small Cell Lung Cancer)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
NEXT Oncology, Irving, Texas, United States
Contact: Study coordinator (Michael Song, MD)NEXT Oncology Virginia, Fairfax, Virginia, United States